Global Vaccine Adjuvants Market Research Report 2023

Global Vaccine Adjuvants Market Research Report 2023

Table of Contents
1 Vaccine Adjuvants Market Overview
1.1 Product Overview and Scope of Vaccine Adjuvants
1.2 Vaccine Adjuvants Segment by Type
1.2.1 Global Vaccine Adjuvants Market Value Comparison by Type (2023-2029)
1.2.2 Aluminum Adjuvant
1.2.3 Emulsions Adjuvant
1.2.4 Others
1.3 Vaccine Adjuvants Segment by Application
1.3.1 Global Vaccine Adjuvants Market Value by Application: (2023-2029)
1.3.2 Human Vaccine
1.3.3 Veterinary Vaccine
1.4 Global Vaccine Adjuvants Market Size Estimates and Forecasts
1.4.1 Global Vaccine Adjuvants Revenue 2018-2029
1.4.2 Global Vaccine Adjuvants Sales 2018-2029
1.4.3 Global Vaccine Adjuvants Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Vaccine Adjuvants Market Competition by Manufacturers
2.1 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Vaccine Adjuvants Average Price by Manufacturers (2018-2023)
2.4 Global Vaccine Adjuvants Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
2.7 Vaccine Adjuvants Market Competitive Situation and Trends
2.7.1 Vaccine Adjuvants Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Vaccine Adjuvants Players Market Share by Revenue
2.7.3 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Vaccine Adjuvants Retrospective Market Scenario by Region
3.1 Global Vaccine Adjuvants Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Vaccine Adjuvants Global Vaccine Adjuvants Sales by Region: 2018-2029
3.2.1 Global Vaccine Adjuvants Sales by Region: 2018-2023
3.2.2 Global Vaccine Adjuvants Sales by Region: 2024-2029
3.3 Global Vaccine Adjuvants Global Vaccine Adjuvants Revenue by Region: 2018-2029
3.3.1 Global Vaccine Adjuvants Revenue by Region: 2018-2023
3.3.2 Global Vaccine Adjuvants Revenue by Region: 2024-2029
3.4 North America Vaccine Adjuvants Market Facts & Figures by Country
3.4.1 North America Vaccine Adjuvants Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Vaccine Adjuvants Sales by Country (2018-2029)
3.4.3 North America Vaccine Adjuvants Revenue by Country (2018-2029)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Vaccine Adjuvants Market Facts & Figures by Country
3.5.1 Europe Vaccine Adjuvants Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Vaccine Adjuvants Sales by Country (2018-2029)
3.5.3 Europe Vaccine Adjuvants Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Vaccine Adjuvants Market Facts & Figures by Country
3.6.1 Asia Pacific Vaccine Adjuvants Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Vaccine Adjuvants Sales by Country (2018-2029)
3.6.3 Asia Pacific Vaccine Adjuvants Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Vaccine Adjuvants Market Facts & Figures by Country
3.7.1 Latin America Vaccine Adjuvants Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Vaccine Adjuvants Sales by Country (2018-2029)
3.7.3 Latin America Vaccine Adjuvants Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Vaccine Adjuvants Market Facts & Figures by Country
3.8.1 Middle East and Africa Vaccine Adjuvants Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Vaccine Adjuvants Sales by Country (2018-2029)
3.8.3 Middle East and Africa Vaccine Adjuvants Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 U.A.E
4 Segment by Type
4.1 Global Vaccine Adjuvants Sales by Type (2018-2029)
4.1.1 Global Vaccine Adjuvants Sales by Type (2018-2023)
4.1.2 Global Vaccine Adjuvants Sales by Type (2024-2029)
4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2018-2029)
4.2 Global Vaccine Adjuvants Revenue by Type (2018-2029)
4.2.1 Global Vaccine Adjuvants Revenue by Type (2018-2023)
4.2.2 Global Vaccine Adjuvants Revenue by Type (2024-2029)
4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2018-2029)
4.3 Global Vaccine Adjuvants Price by Type (2018-2029)
5 Segment by Application
5.1 Global Vaccine Adjuvants Sales by Application (2018-2029)
5.1.1 Global Vaccine Adjuvants Sales by Application (2018-2023)
5.1.2 Global Vaccine Adjuvants Sales by Application (2024-2029)
5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2018-2029)
5.2 Global Vaccine Adjuvants Revenue by Application (2018-2029)
5.2.1 Global Vaccine Adjuvants Revenue by Application (2018-2023)
5.2.2 Global Vaccine Adjuvants Revenue by Application (2024-2029)
5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2018-2029)
5.3 Global Vaccine Adjuvants Price by Application (2018-2029)
6 Key Companies Profiled
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Description and Business Overview
6.1.3 GSK Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.1.4 GSK Vaccine Adjuvants Product Portfolio
6.1.5 GSK Recent Developments/Updates
6.2 CSL Limited
6.2.1 CSL Limited Corporation Information
6.2.2 CSL Limited Description and Business Overview
6.2.3 CSL Limited Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.2.4 CSL Limited Vaccine Adjuvants Product Portfolio
6.2.5 CSL Limited Recent Developments/Updates
6.3 Croda
6.3.1 Croda Corporation Information
6.3.2 Croda Description and Business Overview
6.3.3 Croda Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.3.4 Croda Vaccine Adjuvants Product Portfolio
6.3.5 Croda Recent Developments/Updates
6.4 SEPPIC
6.4.1 SEPPIC Corporation Information
6.4.2 SEPPIC Description and Business Overview
6.4.3 SEPPIC Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 SEPPIC Vaccine Adjuvants Product Portfolio
6.4.5 SEPPIC Recent Developments/Updates
6.5 Novavax
6.5.1 Novavax Corporation Information
6.5.2 Novavax Description and Business Overview
6.5.3 Novavax Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Novavax Vaccine Adjuvants Product Portfolio
6.5.5 Novavax Recent Developments/Updates
6.6 SPI Pharma
6.6.1 SPI Pharma Corporation Information
6.6.2 SPI Pharma Description and Business Overview
6.6.3 SPI Pharma Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.6.4 SPI Pharma Vaccine Adjuvants Product Portfolio
6.6.5 SPI Pharma Recent Developments/Updates
6.7 Phibro
6.6.1 Phibro Corporation Information
6.6.2 Phibro Description and Business Overview
6.6.3 Phibro Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Phibro Vaccine Adjuvants Product Portfolio
6.7.5 Phibro Recent Developments/Updates
6.8 SDA BIO
6.8.1 SDA BIO Corporation Information
6.8.2 SDA BIO Description and Business Overview
6.8.3 SDA BIO Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.8.4 SDA BIO Vaccine Adjuvants Product Portfolio
6.8.5 SDA BIO Recent Developments/Updates
6.9 Invivogen
6.9.1 Invivogen Corporation Information
6.9.2 Invivogen Description and Business Overview
6.9.3 Invivogen Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Invivogen Vaccine Adjuvants Product Portfolio
6.9.5 Invivogen Recent Developments/Updates
6.10 Tj Kaiwei
6.10.1 Tj Kaiwei Corporation Information
6.10.2 Tj Kaiwei Description and Business Overview
6.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Tj Kaiwei Vaccine Adjuvants Product Portfolio
6.10.5 Tj Kaiwei Recent Developments/Updates
6.11 OZ Biosciences
6.11.1 OZ Biosciences Corporation Information
6.11.2 OZ Biosciences Vaccine Adjuvants Description and Business Overview
6.11.3 OZ Biosciences Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.11.4 OZ Biosciences Vaccine Adjuvants Product Portfolio
6.11.5 OZ Biosciences Recent Developments/Updates
6.12 Brenntag Biosector
6.12.1 Brenntag Biosector Corporation Information
6.12.2 Brenntag Biosector Vaccine Adjuvants Description and Business Overview
6.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Brenntag Biosector Vaccine Adjuvants Product Portfolio
6.12.5 Brenntag Biosector Recent Developments/Updates
6.13 MVP Laboratories
6.13.1 MVP Laboratories Corporation Information
6.13.2 MVP Laboratories Vaccine Adjuvants Description and Business Overview
6.13.3 MVP Laboratories Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.13.4 MVP Laboratories Vaccine Adjuvants Product Portfolio
6.13.5 MVP Laboratories Recent Developments/Updates
6.14 Zhuoyue
6.14.1 Zhuoyue Corporation Information
6.14.2 Zhuoyue Vaccine Adjuvants Description and Business Overview
6.14.3 Zhuoyue Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Zhuoyue Vaccine Adjuvants Product Portfolio
6.14.5 Zhuoyue Recent Developments/Updates
6.15 Aphios
6.15.1 Aphios Corporation Information
6.15.2 Aphios Vaccine Adjuvants Description and Business Overview
6.15.3 Aphios Vaccine Adjuvants Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Aphios Vaccine Adjuvants Product Portfolio
6.15.5 Aphios Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Vaccine Adjuvants Industry Chain Analysis
7.2 Vaccine Adjuvants Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Vaccine Adjuvants Production Mode & Process
7.4 Vaccine Adjuvants Sales and Marketing
7.4.1 Vaccine Adjuvants Sales Channels
7.4.2 Vaccine Adjuvants Distributors
7.5 Vaccine Adjuvants Customers
8 Vaccine Adjuvants Market Dynamics
8.1 Vaccine Adjuvants Industry Trends
8.2 Vaccine Adjuvants Market Drivers
8.3 Vaccine Adjuvants Market Challenges
8.4 Vaccine Adjuvants Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
Table 1. Global Vaccine Adjuvants Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Vaccine Adjuvants Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Vaccine Adjuvants Market Competitive Situation by Manufacturers in 2022
Table 4. Global Vaccine Adjuvants Sales (MT) of Key Manufacturers (2018-2023)
Table 5. Global Vaccine Adjuvants Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Vaccine Adjuvants Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Vaccine Adjuvants Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Vaccine Adjuvants Average Price (USD/Kg) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Vaccine Adjuvants, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Vaccine Adjuvants, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Vaccine Adjuvants, Product Type & Application
Table 12. Global Key Manufacturers of Vaccine Adjuvants, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 18. Global Vaccine Adjuvants Sales Market Share by Region (2018-2023)
Table 19. Global Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 20. Global Vaccine Adjuvants Sales Market Share by Region (2024-2029)
Table 21. Global Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Vaccine Adjuvants Revenue Market Share by Region (2018-2023)
Table 23. Global Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Vaccine Adjuvants Revenue Market Share by Region (2024-2029)
Table 25. North America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 27. North America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 28. North America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 32. Europe Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 33. Europe Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Vaccine Adjuvants Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Vaccine Adjuvants Sales by Region (2018-2023) & (MT)
Table 37. Asia Pacific Vaccine Adjuvants Sales by Region (2024-2029) & (MT)
Table 38. Asia Pacific Vaccine Adjuvants Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Vaccine Adjuvants Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 42. Latin America Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 43. Latin America Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Vaccine Adjuvants Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Vaccine Adjuvants Sales by Country (2018-2023) & (MT)
Table 47. Middle East & Africa Vaccine Adjuvants Sales by Country (2024-2029) & (MT)
Table 48. Middle East & Africa Vaccine Adjuvants Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Vaccine Adjuvants Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Vaccine Adjuvants Sales (MT) by Type (2018-2023)
Table 51. Global Vaccine Adjuvants Sales (MT) by Type (2024-2029)
Table 52. Global Vaccine Adjuvants Sales Market Share by Type (2018-2023)
Table 53. Global Vaccine Adjuvants Sales Market Share by Type (2024-2029)
Table 54. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Vaccine Adjuvants Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Vaccine Adjuvants Revenue Market Share by Type (2018-2023)
Table 57. Global Vaccine Adjuvants Revenue Market Share by Type (2024-2029)
Table 58. Global Vaccine Adjuvants Price (USD/Kg) by Type (2018-2023)
Table 59. Global Vaccine Adjuvants Price (USD/Kg) by Type (2024-2029)
Table 60. Global Vaccine Adjuvants Sales (MT) by Application (2018-2023)
Table 61. Global Vaccine Adjuvants Sales (MT) by Application (2024-2029)
Table 62. Global Vaccine Adjuvants Sales Market Share by Application (2018-2023)
Table 63. Global Vaccine Adjuvants Sales Market Share by Application (2024-2029)
Table 64. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Vaccine Adjuvants Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Vaccine Adjuvants Revenue Market Share by Application (2018-2023)
Table 67. Global Vaccine Adjuvants Revenue Market Share by Application (2024-2029)
Table 68. Global Vaccine Adjuvants Price (USD/Kg) by Application (2018-2023)
Table 69. Global Vaccine Adjuvants Price (USD/Kg) by Application (2024-2029)
Table 70. GSK Corporation Information
Table 71. GSK Description and Business Overview
Table 72. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 73. GSK Vaccine Adjuvants Product
Table 74. GSK Recent Developments/Updates
Table 75. CSL Limited Corporation Information
Table 76. CSL Limited Description and Business Overview
Table 77. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 78. CSL Limited Vaccine Adjuvants Product
Table 79. CSL Limited Recent Developments/Updates
Table 80. Croda Corporation Information
Table 81. Croda Description and Business Overview
Table 82. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 83. Croda Vaccine Adjuvants Product
Table 84. Croda Recent Developments/Updates
Table 85. SEPPIC Corporation Information
Table 86. SEPPIC Description and Business Overview
Table 87. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 88. SEPPIC Vaccine Adjuvants Product
Table 89. SEPPIC Recent Developments/Updates
Table 90. Novavax Corporation Information
Table 91. Novavax Description and Business Overview
Table 92. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 93. Novavax Vaccine Adjuvants Product
Table 94. Novavax Recent Developments/Updates
Table 95. SPI Pharma Corporation Information
Table 96. SPI Pharma Description and Business Overview
Table 97. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 98. SPI Pharma Vaccine Adjuvants Product
Table 99. SPI Pharma Recent Developments/Updates
Table 100. Phibro Corporation Information
Table 101. Phibro Description and Business Overview
Table 102. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 103. Phibro Vaccine Adjuvants Product
Table 104. Phibro Recent Developments/Updates
Table 105. SDA BIO Corporation Information
Table 106. SDA BIO Description and Business Overview
Table 107. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 108. SDA BIO Vaccine Adjuvants Product
Table 109. SDA BIO Recent Developments/Updates
Table 110. Invivogen Corporation Information
Table 111. Invivogen Description and Business Overview
Table 112. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 113. Invivogen Vaccine Adjuvants Product
Table 114. Invivogen Recent Developments/Updates
Table 115. Tj Kaiwei Corporation Information
Table 116. Tj Kaiwei Description and Business Overview
Table 117. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 118. Tj Kaiwei Vaccine Adjuvants Product
Table 119. Tj Kaiwei Recent Developments/Updates
Table 120. OZ Biosciences Corporation Information
Table 121. OZ Biosciences Description and Business Overview
Table 122. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 123. OZ Biosciences Vaccine Adjuvants Product
Table 124. OZ Biosciences Recent Developments/Updates
Table 125. Brenntag Biosector Corporation Information
Table 126. Brenntag Biosector Description and Business Overview
Table 127. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 128. Brenntag Biosector Vaccine Adjuvants Product
Table 129. Brenntag Biosector Recent Developments/Updates
Table 130. MVP Laboratories Corporation Information
Table 131. MVP Laboratories Description and Business Overview
Table 132. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 133. MVP Laboratories Vaccine Adjuvants Product
Table 134. MVP Laboratories Recent Developments/Updates
Table 135. Zhuoyue Corporation Information
Table 136. Zhuoyue Description and Business Overview
Table 137. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 138. Zhuoyue Vaccine Adjuvants Product
Table 139. Zhuoyue Recent Developments/Updates
Table 140. Aphios Corporation Information
Table 141. Aphios Description and Business Overview
Table 142. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 143. Aphios Vaccine Adjuvants Product
Table 144. Aphios Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Vaccine Adjuvants Distributors List
Table 148. Vaccine Adjuvants Customers List
Table 149. Vaccine Adjuvants Market Trends
Table 150. Vaccine Adjuvants Market Drivers
Table 151. Vaccine Adjuvants Market Challenges
Table 152. Vaccine Adjuvants Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Vaccine Adjuvants
Figure 2. Global Vaccine Adjuvants Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Vaccine Adjuvants Market Share by Type in 2022 & 2029
Figure 4. Aluminum Adjuvant Product Picture
Figure 5. Emulsions Adjuvant Product Picture
Figure 6. Others Product Picture
Figure 7. Global Vaccine Adjuvants Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Vaccine Adjuvants Market Share by Application in 2022 & 2029
Figure 9. Human Vaccine
Figure 10. Veterinary Vaccine
Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 12. Global Vaccine Adjuvants Market Size (2018-2029) & (US$ Million)
Figure 13. Global Vaccine Adjuvants Sales (2018-2029) & (MT)
Figure 14. Global Vaccine Adjuvants Average Price (USD/Kg) & (2018-2029)
Figure 15. Vaccine Adjuvants Report Years Considered
Figure 16. Vaccine Adjuvants Sales Share by Manufacturers in 2022
Figure 17. Global Vaccine Adjuvants Revenue Share by Manufacturers in 2022
Figure 18. The Global 5 and 10 Largest Vaccine Adjuvants Players: Market Share by Revenue in 2022
Figure 19. Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 20. Global Vaccine Adjuvants Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 21. North America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 22. North America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 23. U.S. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 24. Canada Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Europe Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 26. Europe Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 27. Germany Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 28. France Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. U.K. Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. Italy Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Russia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Asia Pacific Vaccine Adjuvants Sales Market Share by Region (2018-2029)
Figure 33. Asia Pacific Vaccine Adjuvants Revenue Market Share by Region (2018-2029)
Figure 34. China Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 35. Japan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. South Korea Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. India Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. Australia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. China Taiwan Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. Indonesia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Thailand Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Malaysia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Philippines Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 45. Latin America Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Middle East & Africa Vaccine Adjuvants Sales Market Share by Country (2018-2029)
Figure 50. Middle East & Africa Vaccine Adjuvants Revenue Market Share by Country (2018-2029)
Figure 51. Turkey Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 52. Saudi Arabia Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. U.A.E Vaccine Adjuvants Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. Global Sales Market Share of Vaccine Adjuvants by Type (2018-2029)
Figure 55. Global Revenue Market Share of Vaccine Adjuvants by Type (2018-2029)
Figure 56. Global Vaccine Adjuvants Price (USD/Kg) by Type (2018-2029)
Figure 57. Global Sales Market Share of Vaccine Adjuvants by Application (2018-2029)
Figure 58. Global Revenue Market Share of Vaccine Adjuvants by Application (2018-2029)
Figure 59. Global Vaccine Adjuvants Price (USD/Kg) by Application (2018-2029)
Figure 60. Vaccine Adjuvants Value Chain
Figure 61. Vaccine Adjuvants Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Antioxidant Vitamins Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 100

The global Antioxidant Vitamins market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Antioxidant Vitamins is estimated to increase from $ million in 2023 to reach $ millio......

Global Clavulanate Potassium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Clavulanate Potassium market was valued at US$ 446.6 million in 2023 and is anticipated to reach US$ 637.2 million by 2030, witnessing a CAGR of 5.2% during The forecast period 2024-2030. North American market for Clavulanate Potassium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Clavulanate Potassium is estimated to increase from $ million in 2023......

Global Amoxicillin Sodium Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 84

The global Amoxicillin Sodium market was valued at US$ 460.9 million in 2023 and is anticipated to reach US$ 735.1 million by 2030, witnessing a CAGR of 7.0% during The forecast period 2024-2030. North American market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Amoxicillin Sodium is estimated to increase from $ million in 2023 to reach......

Global Melatonin Supplements Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Melatonin Supplements market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Melatonin Supplements is estimated to increase from $ million in 2023 to reach $ mil......

Global Sleeping Pills (Prescription Drugs) Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 93

The global Sleeping Pills (Prescription Drugs) market was valued at US$ 1022.3 million in 2023 and is anticipated to reach US$ 1437.8 million by 2030, witnessing a CAGR of 4.9% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical......

Global Sleeping Pills Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94

The global Sleeping Pills market was valued at US$ 2042.3 million in 2023 and is anticipated to reach US$ 2979.5 million by 2030, witnessing a CAGR of 3.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Zinc Oral Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Oral Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Oral Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a......

Global Zinc Drops Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85

The global Zinc Drops market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Zinc Drops is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % duri......

Global Anti-Infectives Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78

The global Anti-Infectives market was valued at US$ 22700 million in 2023 and is anticipated to reach US$ 27480 million by 2030, witnessing a CAGR of 2.3% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estima......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs